JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2000) 164, 307-314       DOI: 10.1677/joe.0.1640307
© 2000 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iizuka, K
Right arrow Articles by Matsuzawa, Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iizuka, K
Right arrow Articles by Matsuzawa, Y
Journal of Endocrinology, Vol 164, Issue 3, 307-314
Copyright © 2000 by Society for Endocrinology


Articles

Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic beta-cell line

K Iizuka, H Nakajima, A Ono, K Okita, J Miyazaki, J Miyagawa, M Namba, T Hanafusa, and Y Matsuzawa


Glucose-6-phosphatase (G-6-Pase) hydrolyzes glucose-6-phosphate to glucose, reciprocal with the so-called glucose sensor, glucokinase, in pancreatic beta cells. To study the role of G-6-Pase in glucose-stimulated insulin secretion from beta cells, we have introduced rat G-6-Pase catalytic subunit cDNA and have established permanent clones with 3-, 7- and 24-fold G-6-Pase activity of the mouse beta-cell line, MIN6. In these clones, glucose usage and ATP production in the presence of 5.5 or 25 mM glucose were reduced, and glucose-stimulated insulin secretion was decreased in proportion to the increased G-6-Pase activity. In addition, insulin secretory capacity in response to d-fructose and pyruvate was unchanged; however, 25 mM glucose-stimulated insulin secretion and intracellular calcium response were completely inhibited. In the clone with 24-fold G-6-Pase activity, changes in intracellular NAD(P)H autofluorescence in response to 25 mM glucose were reduced, but the changes with 20 mM fructose and 20 mM pyruvate were not altered. Stable overexpression of G-6-Pase in beta cells resulted in attenuation of the overall glucose-stimulated metabolic responses corresponding to the degree of overexpression. This particular experimental manipulation shows that the possibility exists of modulating glucose-stimulated insulin release by thoroughly altering glucose cycling at the glucokinase/G-6-Pase step.


This article has been cited by other articles:


Home page
DiabetesHome page
X. Li, Y.-H. Shu, A. H. Xiang, E. Trigo, J. Kuusisto, J. Hartiala, A. J. Swift, M. Kawakubo, H. M. Stringham, L. L. Bonnycastle, et al.
Additive Effects of Genetic Variation in GCK and G6PC2 on Insulin Secretion and Fasting Glucose
Diabetes, December 1, 2009; 58(12): 2946 - 2953.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Dos Santos, P. Bougneres, and D. Fradin
A Single-Nucleotide Polymorphism in a Methylatable Foxa2 Binding Site of the G6PC2 Promoter Is Associated With Insulin Secretion In Vivo and Increased Promoter Activity In Vitro
Diabetes, February 1, 2009; 58(2): 489 - 492.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Endocr. Rev., October 1, 2004; 25(5): 807 - 830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Petrolonis, Q. Yang, P. J. Tummino, S. M. Fish, A. E. Prack, S. Jain, T. F. Parsons, P. Li, N. A. Dales, L. Ge, et al.
Enzymatic Characterization of the Pancreatic Islet-specific Glucose-6-Phosphatase-related Protein (IGRP)
J. Biol. Chem., April 2, 2004; 279(14): 13976 - 13983.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Yamagata, T. Nammo, M. Moriwaki, A. Ihara, K. Iizuka, Q. Yang, T. Satoh, M. Li, R. Uenaka, K. Okita, et al.
Overexpression of Dominant-Negative Mutant Hepatocyte Nuclear Factor-1{alpha} in Pancreatic {beta}-Cells Causes Abnormal Islet Architecture With Decreased Expression of E-Cadherin, Reduced {beta}-cell Proliferation, and Diabetes
Diabetes, January 1, 2002; 51(1): 114 - 123.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. J. Bischof, C. C. Martin, C. A. Svitek, B. T. Stadelmaier, L. A. Hornbuckle, J. K. Goldman, J. K. Oeser, J. C. Hutton, and R. M. O’Brien
Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein Gene Promoter by In Situ Footprinting: Correlation With Fusion Gene Expression in the Islet-Derived {beta}TC-3 and Hamster Insulinoma Tumor Cell Lines
Diabetes, March 1, 2001; 50(3): 502 - 514.
[Abstract] [Full Text]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Endocrinology.